Financials
- Market Capitalization 772.51 M
- Employee 102
- Founded 2010
- CEO Brian Stuglik
- Website www.verastem.com
- Headquarter Massachusetts, United States
- FIGI BBG001J2LSK5
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.56
Relación precio/flujo de caja
17.31
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2584 | ANNX Annexon, Inc. - common stock | 4.03 USD | +0.25% | -6.06% | +1.51% | +29.17% | 764.00 M USD | ||
| 2586 | CADL Candel Therapeutics, Inc. - Common Stock | 9.94 USD | 0.00% | -2.93% | -4.51% | +58.28% | 760.59 M USD | ||
| 2596 | LXRX Lexicon Pharmaceuticals, Inc. - Common Stock | 1.65 USD | -1.79% | -6.78% | -16.67% | +9.27% | 734.18 M USD | ||
| 2605 | SLDB Solid Biosciences Inc. - Common Stock | 6.90 USD | +0.44% | -0.29% | -21.77% | +21.05% | 739.85 M USD |